Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

One-Compartment Model: IV Infusion01:09

One-Compartment Model: IV Infusion

543
Intravenous (IV) infusion is often utilized when continuous and controlled drug delivery is necessary, such as during surgery or in the treatment of chronic diseases. This method offers numerous advantages, including immediate drug action, precise control over dosage, and bypassing the first-pass metabolism.
The one-compartment model for IV infusion uses mathematical equations to describe the rate of change in drug quantity in the body. At steady-state or infusion equilibrium, the drug input...
543
Two-Compartment Open Model: IV Infusion01:15

Two-Compartment Open Model: IV Infusion

631
A two-compartment model is a vital tool in pharmacokinetics, providing an essential understanding of drug behavior, especially for those administered via zero-order intravenous infusion. This model outlines two compartments: the central compartment, where elimination occurs, and the peripheral compartment.
The model illustrates the decrease in plasma drug concentration from the central compartment with a specific equation. It shows that under steady-state conditions, the drug's input rate...
631
Tissue Transplantation01:24

Tissue Transplantation

1.1K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.1K
IV Infusion to Oral Dosing: Conversion Methods01:28

IV Infusion to Oral Dosing: Conversion Methods

13
The development of extended-release formulations has facilitated the transition from intravenous to oral medication, offering a more convenient and patient-friendly approach to drug administration. This transition, however, requires careful management to ensure that therapeutic drug levels are maintained, preserving efficacy and avoiding adverse effects. Understanding pharmacokinetic principles and dosage calculations is critical during this process.Pharmacokinetics of the...
13
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

514
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
514
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

278
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
278

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Unusual Suspects: Esophageal Polyps Causing Dysphagia.

ACG case reports journal·2026
Same author

Project TEACH School-Focused Consultation and Community Collaboration: A Multidisciplinary Pilot Intervention to Reduce Mental Health Disparities in Upstate, NY.

Healthcare (Basel, Switzerland)·2026
Same author

Chronic Hepatitis C in the Direct-Acting Antivirals Era: Carcinogenesis and Clinical Implications.

Diseases (Basel, Switzerland)·2025
Same author

Chronic Hepatitis B: Current Management and Future Directions.

Diseases (Basel, Switzerland)·2025
Same author

Association of TP53 with Defective Long Chain 3-Hydroxy acyl-CoA Dehydrogenase Induced Non-Cirrhotic Hepatocellular Carcinoma.

Cancers·2025
Same author

Effects of Diet and Exercise on Mitochondrial Health in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Role of Ceramides.

Nutrients·2025

Related Experiment Video

Updated: Feb 15, 2026

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine
09:54

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine

Published on: November 4, 2018

8.6K

Hepatocyte transplantation: Consider infusion before incision.

Ryan D Heath1, Furkan Ertem2, Bhupinder S Romana1

  • 1Division of Gastroenterology and Hepatology, University of Missouri, Columbia, MO 65212, United States.

World Journal of Transplantation
|January 10, 2018
PubMed
Summary

Human hepatocyte transplantation shows promise as a bridge or alternative to liver transplantation. Ongoing advancements in cell delivery, culture, monitoring, and immunosuppression aim to improve graft survival and function, potentially delaying the need for orthotopic liver transplantation.

Keywords:
Cell therapyGraftHepatocyeLiverOrthotopicTransplantation

More Related Videos

Intrasplenic Transplantation of Hepatocytes After Partial Hepatectomy in NOD.SCID Mice
11:24

Intrasplenic Transplantation of Hepatocytes After Partial Hepatectomy in NOD.SCID Mice

Published on: February 10, 2018

14.8K
Minimizing Post-Infusion Portal Vein Bleeding during Intrahepatic Islet Transplantation in Mice
06:41

Minimizing Post-Infusion Portal Vein Bleeding during Intrahepatic Islet Transplantation in Mice

Published on: May 10, 2021

4.4K

Related Experiment Videos

Last Updated: Feb 15, 2026

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine
09:54

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine

Published on: November 4, 2018

8.6K
Intrasplenic Transplantation of Hepatocytes After Partial Hepatectomy in NOD.SCID Mice
11:24

Intrasplenic Transplantation of Hepatocytes After Partial Hepatectomy in NOD.SCID Mice

Published on: February 10, 2018

14.8K
Minimizing Post-Infusion Portal Vein Bleeding during Intrahepatic Islet Transplantation in Mice
06:41

Minimizing Post-Infusion Portal Vein Bleeding during Intrahepatic Islet Transplantation in Mice

Published on: May 10, 2021

4.4K

Area of Science:

  • Hepatology and Regenerative Medicine
  • Transplantation Biology

Background:

  • Human hepatocyte transplantation is being investigated as a potential treatment for liver failure.
  • The technique serves as a possible bridge or alternative to orthotopic liver transplantation (OLT).

Purpose of the Study:

  • To review the advancements in human hepatocyte transplantation over the past three decades.
  • To highlight the potential for improved graft survival and function with further technique refinement.

Main Methods:

  • Review of historical developments in hepatocyte transplantation techniques.
  • Analysis of changes in cell delivery, culture, graft monitoring, and immunosuppression protocols.

Main Results:

  • Significant progress has been made in human hepatocyte transplantation over 30 years.
  • Key areas of development include cell source, preparation, delivery methods, and immunosuppression strategies.

Conclusions:

  • Further refinements in hepatocyte transplantation techniques are expected to enhance graft survival and function.
  • Improved outcomes may significantly delay or obviate the need for orthotopic liver transplantation in patients with liver disease.